FrançaisAre analysts right about Exponent, Inc. (EXPO)?
📈 See the interactive version (live chart) →
Historical analyst accuracy
For Exponent, Inc., we replayed every analyst price target of the past 12 months and measured the real outcome: 50% were profitable, average return +12% (12 calls). At 3 months: +6% average return (56% profitable). The higher the %, the more often analysts were right on this stock.
Most reliable analysts on this stock (past track record)
Their past track record on this stock (targets replayed against real prices) — not a forecast of what will happen.
| Analyst / broker | Calls i | % profitable i | Avg return i |
|---|---|---|---|
| Truist Securities | 6 | 33% | -4% |
Valuation
Is Exponent, Inc. overvalued, and is it a good time to buy Exponent, Inc. right now? If you're wondering, here's a recap to make up your own mind: Exponent, Inc.'s valuation vs its sector median, to weigh alongside analyst reliability (above) and past performance. Educational information, not buy advice.
The P/E (price ÷ earnings per share) = how many years of earnings you pay for the stock. The higher it is, the more growth the market expects — but the pricier the stock, so more vulnerable if growth disappoints. The forward P/E uses next year's expected earnings: lower than the current P/E = rising expected earnings. We compare it to the sector median to see whether the stock is expensive relative to its peers.
| Metric | Exponent, Inc. | Sector median (Industrials) |
|---|---|---|
| P/E | 31.9 | 29.2 |
| Forward P/E | 25.1 | 19.5 |
| Net margin | 20% | 11% |
👉 Exponent, Inc. is valued in line with its sector (31.9 vs 29.2).
📖 P/E, PEG, margin…: see the glossary
💵 Dividend : Exponent, Inc. pays about $1.22/share/yr → 2.04% yield. what is this?
Frequently asked questions
Is Exponent, Inc. a buy right now?
The analyst consensus on Exponent, Inc. (EXPO) is "Buy" (5 bullish, 0 bearish calls over 12 months). This is not advice: historically, 50% of their targets on this stock turned out profitable over 1 year.
What is Exponent, Inc.'s price target?
The median 12-month price target is $81.00 (+14% vs $71.15), ranging from $72.00 to $90.00 (2 analysts).
Are analysts accurate on Exponent, Inc.?
Over 1 year, 50% of analyst targets on Exponent, Inc. were profitable, for an average return of +12% (across 12 timestamped calls). This is JPI Invest's accuracy metric.
What is the Exponent, Inc. stock forecast?
Analysts target a median of $81.00 within 12 months, i.e. +14% vs the current price. The most bullish targets $90.00, the most cautious $72.00.
What is the Exponent, Inc. stock forecast for 2026 or long term (2030)?
Note: analyst targets are 12-month (median $81.00, +14%), NOT 2030. No reliable 5-10 year price forecast exists (« 2030 prediction » models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (50%), and the stock's past trajectory.
Is Exponent, Inc. overvalued?
Its P/E is 31.9, forward P/E 25.1. A forward P/E lower than the current P/E means earnings are expected to grow.
📊 See the full interactive analysis of Exponent, Inc. →
What is JPI Invest?
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best — on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
- 🏆 Analyst leaderboard by real reliability (beating their sector, not just riding the rally)
- 🎯 What to buy: 3 backtested methods over 6 years, from cautious to aggressive
- 💬 AI assistant: ask anything about any stock, with the numbers
- 📊 Portfolio tracking + 🔔 price alerts by email
⚠️ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.